Literature DB >> 9300244

A circadian rhythm in lipid mobilization which is altered in IDDM.

E Hagström-Toft1, J Bolinder, U Ungerstedt, P Arner.   

Abstract

It is not clear how circadian lipolysis and circulating concentrations of non-esterified fatty acids (NEFA) are altered in intensively treated insulin-dependent diabetic (IDDM) patients. Ten IDDM patients on an intensive insulin regimen and eight healthy control subjects were investigated under ordinary living conditions for 27 h by microdialysis of subcutaneous adipose tissue. The true tissue glycerol concentration and adipose blood flow changes were monitored as an index of lipolysis. A circadian pattern in adipose tissue lipolysis was observed in both groups, decreasing during the day and increasing during evening-night. The daytime decrease was normal, but the evening-night rise was elevated in IDDM (p = 0.03). Circulating NEFA decreased during the day and increased at night. The latter increase was enhanced threefold in IDDM (p = 0.003) and correlated with fasting glucose levels (r = 0.77). Nocturnal growth hormone (GH) was increased fivefold in IDDM and correlated to nocturnal lipolysis (r = 0.83). Adipose tissue blood flow increased during the night in a similar fashion in both groups. Near-normalization of glucose for 24 h in IDDM did not affect the nocturnal increases in NEFA, GH and lipolysis. In conclusion, a circadian rhythm in lipolysis was found. Increased lipolytic rates during evening-night may at least in part raise nocturnal circulating NEFA. Nocturnal NEFA and lipolysis are further enhanced in IDDM, maybe due to elevated GH, but not to insulinopenia or hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300244     DOI: 10.1007/s001250050789

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

Review 2.  Circadian metabolism in the light of evolution.

Authors:  Zachary Gerhart-Hines; Mitchell A Lazar
Journal:  Endocr Rev       Date:  2015-04-30       Impact factor: 19.871

3.  Lack of Day/Night variation in fibroblast growth factor 21 levels in young healthy men.

Authors:  J-P Foo; K N Aronis; J P Chamberland; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-12-26       Impact factor: 5.095

4.  NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test.

Authors:  Ray C Boston; Peter J Moate
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-18       Impact factor: 3.619

5.  The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

Authors:  R M Williams; R Amin; F Shojaee-Moradie; A M Umpleby; C L Acerini; D B Dunger
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

6.  Circadian Rhythms in Hormone-sensitive Lipase in Human Adipose Tissue: Relationship to Meal Timing and Fasting Duration.

Authors:  María Arredondo-Amador; Carolina Zambrano; Agné Kulyté; Juán Luján; Kun Hu; Fermín Sánchez de Medina; Frank A J L Scheer; Peter Arner; Mikael Ryden; Olga Martínez-Augustin; Marta Garaulet
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

7.  Fatty Acids, Obesity and Insulin Resistance.

Authors:  Peter Arner; Mikael Rydén
Journal:  Obes Facts       Date:  2015       Impact factor: 3.942

8.  Circulating biomarkers of nitric oxide bioactivity and impaired muscle vasoreactivity to exercise in adults with uncomplicated type 1 diabetes.

Authors:  Elodie Lespagnol; Sémah Tagougui; Bernadette O Fernandez; Farid Zerimech; Régis Matran; Patrice Maboudou; Serge Berthoin; Amandine Descat; Isabelle Kim; Mehdi Pawlak-Chaouch; Julien Boissière; Eric Boulanger; Martin Feelisch; Pierre Fontaine; Elsa Heyman
Journal:  Diabetologia       Date:  2020-11-21       Impact factor: 10.122

9.  Time-of-day and Meal Size Effects on Clinical Lipid Markers.

Authors:  Leilah K Grant; Charles A Czeisler; Steven W Lockley; Shadab A Rahman
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

10.  A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System.

Authors:  S Schaller; S Willmann; J Lippert; L Schaupp; T R Pieber; A Schuppert; T Eissing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.